NCT02322645View on ClinicalTrials.gov

Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

Eszopiclone Tablets 3 mg

Trial Locations (1)

380 054

BA Research India Limited, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY